证券代码：300757 证券简称：罗博特科 公告编号：2025-064 罗博特科智能科技股份有限公司 股东询价转让定价情况提示性公告 公司股东宁波科骏企业管理咨询中心（有限合伙）保证向本公司提供的信息 内容真实、准确和完整，不存在虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要提示： 一、本次询价转让初步定价 （一）经向机构投资者询价后，初步确定的转让价格为 130.08 元/股。 （二）参与本次询价转让报价及申购的机构投资者家数为 20 家，涵盖了基金 管理公司、合格境外机构投资者、证券公司、私募基金管理人等专业机构投资者。 参与本次询价转让报价及申购的机构投资者合计有效认购股份数量为 2,120,000 股， 对应的有效认购倍数为 1.05 倍。 二、风险提示 （一）本次询价转让受让方及受让股数仅为初步结果，尚存在拟转让股份被司 法冻结、扣划等风险。询价转让的最终结果以中国证券登记结算有限责任公司深圳 分公司最终办理结果为准。 （二）本次询价转让不涉及公司控制权变更，不会影响公司治理结构和持续经 营。 1 根据2025年8月7日询价申购情况，初步确 ...

Group 1 - Company Fudi Technology has recently completed the sample delivery of sulfide all-solid-state batteries to a leading humanoid robot client, indicating progress in solid-state battery applications in the robotics sector [1] - Fudi Technology is also in ongoing discussions with several other leading humanoid robot companies regarding solid-state battery needs, suggesting a positive trend in demand [1] Group 2 - Company Three Gorges Energy announced plans to issue public infrastructure REITs backed by its wholly-owned subsidiary's offshore wind power project, aiming to optimize capital structure and provide new financing channels [2] - The company intends to subscribe to 34% of the fund shares, while its affiliate, Three Gorges Capital Holdings, plans to subscribe to 10%, indicating strong internal support for the project [2] Group 3 - Shareholder Ningbo Kejun Enterprise Management Consulting Center plans to transfer 201,230 shares of Robotech, representing 1.20% of the company's total equity, which may raise concerns regarding corporate governance and future development [3] - The market will need to monitor the impact of shareholder actions on the company's long-term performance [3]

Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved an operating income of 4.258 billion yuan and a net profit of 1.123 billion yuan in the first half of 2025, with total comprehensive income of 1.106 billion yuan [3] - Shanghai Pudong Development Bank's net profit for the first half of 2025 was 29.737 billion yuan, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [6] - Xianhe Co. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [7] - Shengmei Shanghai reported a net profit of 696 million yuan for the first half of 2025, representing a year-on-year increase of 56.99% [14] Group 2: Regulatory and Corporate Actions - Sino Medical's subsidiary received breakthrough medical device designation from the FDA for its intracranial atherosclerosis treatment product, marking it as the first of its kind globally [2] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8] - Tianyang Technology is planning to purchase equity in Tonglian Financial Services, with key transaction details still under negotiation [10] - Dongfang Guoxin's major shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [5] - Filinger's president reduced his holdings by 8,600 shares during a period of stock price volatility, while other executives did not sell shares [4]

Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved a net profit of 1.123 billion yuan in the first half of 2025, with total operating income of 4.258 billion yuan and total comprehensive income of 1.106 billion yuan [1] - Shanghai Pudong Development Bank reported a net profit of 29.737 billion yuan for the first half of 2025, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [4] - Xianhe Co., Ltd. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [5] - Shunbo Alloy reported a net profit growth of 110.56% year-on-year for the first half of 2025 [12] Group 2: Regulatory and Corporate Actions - Sino Medical announced that its subsidiary received breakthrough medical device designation from the FDA for a new intracranial atherosclerosis treatment product, marking a significant milestone as the first of its kind globally [1] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6][7] - Tianyang Technology is planning to purchase equity in Tonglian Jinfu and related companies, with key transaction details still under negotiation [8] - Filinger reported stock price fluctuations, with the president reducing his holdings by 8,600 shares during a period of abnormal trading activity [2] - Dongfang Guoxin's controlling shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [3]

智通财经APP讯，罗博特科(300757.SZ)公告，公司股东宁波科骏企业管理咨询中心(有限合伙)拟参与询 价转让;出让方拟转让股份总数为201.23万股，占罗博特科总股本的比例为1.20%。 ...

罗博特科（300757）(300757.SZ)公告，公司股东宁波科骏企业管理咨询中心(有限合伙)拟参与询价转 让;出让方拟转让股份总数为201.23万股，占罗博特科总股本的比例为1.20%。 ...

罗博特科智能科技股份有限公司 股东询价转让计划书 股东宁波科骏企业管理咨询中心（有限合伙）保证向罗博特科智能科技股份 有限公司提供的信息内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对 其真实性、准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 一、拟参与转让的股东情况 证券代码：300757 证券简称：罗博特科 公告编号：2025-063 （一）出让方的名称、持股数量、持股比例 出让方委托中国国际金融股份有限公司（以下简称"中金公司"）组织实施罗博 特科首发前股东询价转让（以下简称"本次询价转让"）。截至2025年8月5日，出让 方所持首发前股份的数量、占总股本比例情况如下： | 序号 | 拟参与转让股东的名称 | 持股数量（股） | 持股比例 | | --- | --- | --- | --- | | 1 | 宁波科骏企业管理咨询中心（有限合伙） | 10,697,540 | 6.38% | 本次拟参与询价转让的股东为宁波科骏企业管理咨询中心（有限合伙）（ 以下合称"出让方"），公司实际控制人直接或间接持有罗博特科智能科技 股份有限公 ...

中国国际金融股份有限公司 关于罗博特科智能科技股份有限公司股东 向特定机构投资者询价转让股份 相关资格的核查意见 （北京市朝阳区建国门外大街 1 号国贸大厦 2 座 27 层及 28 层） （以下简称"《指引第 16 号》"）等相关规定，中金公司对参与本次询价转让股东的 相关资格进行核查，并出具本核查意见。 一、本次询价转让的委托 中金公司收到出让方关于本次询价转让的委托，委托中金公司组织实施本次询价 转让。 二、关于参与本次询价转让股东相关资格的核查情况 （一）核查过程 根据相关法规要求，中金公司对出让方的相关资格进行了核查，包括核查出让方 提供的工商登记文件、出让方针对本次询价转让出具的《承诺及声明函》等并通过公 开信息渠道检索等方式对出让方资格进行核查，同时收集了相关核查底稿。 1 中国国际金融股份有限公司（以下简称"中金公司"）受罗博特科智能科技股份 有限公司（以下简称"罗博特科"）股东宁波科骏企业管理咨询中心（有限合伙） （以下简称"出让方"）委托，组织实施本次罗博特科首发前股东向特定机构投资者 询价转让（以下简称"本次询价转让"）。 根据《上市公司股东减持股份管理暂行办法》《深圳证券交易所创业板股 ...

Core Viewpoint - Company ficonTEC has confirmed collaborations with both Teradyne and Advantest, but specific details of these partnerships are considered trade secrets and cannot be disclosed without authorization [1] Group 1 - Company ficonTEC is engaged in partnerships with Teradyne and Advantest [1] - The nature of the collaborations is classified as commercial secrets [1] - Company emphasizes the importance of adhering to legal regulations regarding information disclosure [1]

8月4日，沪深两融数据显示，罗博特科获融资买入额1.30亿元，居两市第219位，当日融资偿还额1.51亿 元，净卖出2029.17万元。 融券方面，当日融券卖出0.13万股，净卖出0.11万股。 最近三个交易日，31日-4日，罗博特科分别获融资买入2.82亿元、1.56亿元、1.30亿元。 ...